Didymin
Didymin has antioxidant property. Didymin induces apoptosis by inhibiting N-Myc and upregulating RKIP in neuroblastoma, may used for neuroblastoma therapy. Didymin may be a potential therapeutic molecule for the treatment of neurodegenerative disorders associated with oxidative stress.
Product Specifications
CAS Number
14259-47-3
Purity
>98% (HPLC)
Solubility
In Vitro: DMSO : 250 mg/mL (420.48 mM)
Smiles
C[C@H]1[C@@H] ([C@H] ([C@H] ([C@@H] (O1) OC[C@@H]1[C@H] ([C@@H] ([C@H] ([C@@H] (O1) Oc1cc (c2C (=O) C[C@H] (Oc2c1) c1ccc (cc1) OC) O) O) O) O) O) O) O
Molecular Formula
C28H34O14
Molecular Weight
594.57
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
037207-ML750 100 µL
JMJD3, NT (KDM6B, JMJD3, KIAA0346, Lysine-specific demethylase 6B, JmjC domain-containing protein 3, Jumonji domain-containing protein 3, Lysine demethylase 6B) (MaxLight 750) discontinued
Sign In for Pricing
View Details 